It is a kind of commonly used anti plasmin hemostatic drugs for SAH, it has function of anti fibrinolytic, it will produce a competitive inhibition with plasminogen activator and inhibit the process of plasminogen converting into plasmin, it also has some direct inhibition function to plasmin, it can slow down the process of fibrin splitting into peptides and amino acids. It is the commonly used anti fibrinolytic agents in clinic. It can inhibit the activation factor of fibrinolytic enzyme and prevent it from being activated to turning into plasmin, thereby prolong the dissolved period of blood clots which block the breach and decrease the ratio of bleeding again during preparation for operation.
Assay: 98% Art No. AGS0007B
Quality standard: company standard
Appearance: it is white or off white powder
Packing: 25kg/barrel
Application: It can be used for the synthesis of organic materials or pharmaceutical intermediate; it is also used in synthesis research of scientific research units
1. It can be used as biochemical reagent
2. It can be used in organic synthesis as anti fibrin dissolve enzyme reagent.
3. It can be used as a hemostatic drug. Aminocaproic acid can be used to treat fibrinolytic bleeding, such as trauma or operation bleeding of brain, lung, prostate, uterus, adrenal and thyroid gland, etc. It can be used as early medication or preoperative medication during operation, it can reduce gastrostaxis during surgical operation and reduce the volume of blood transfusion.